comments
Respond
Comment on the article
Add a citation
Reply with an article
Start a new topic
Edit
Edit article
Delete article
Share
Invite
Link
Embed
Social media
Avatar
View
Graph
Explorer
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 levels
Load all levels
All
Dagre
Focus
Down
Load 1 level
Load 2 levels
Load 3 levels
Load 4 level
Load all levels
All
Tree
SpaceTree
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Radial
Focus
Expanding
Load 1 level
Load 2 levels
Load 3 levels
Down
All
Down
Box
Focus
Expanding
Down
Up
All
Down
Article ✓
Outline
Document
Down
All
Page
Canvas
Time
Timeline
Calendar
Updates
Subscribe to updates
Get updates
Past 24 hours
Past week
Past month
Past year
Pause updates
Contact us
Nonpharmaceutical Interventions (NPIs)
Tags: NPI, quarantine,
quarantines, social distancing, mobility restrictions, lockdowns, masks, mask
RELATED ARTICLES
Explain
⌅
EIDM
EIDM ☜The Emerging Infectious Diseases Modelling Initiative (EIDM) – by the Public Health Agency of Canada and NSERC – aims to establish multi-disciplinary network(s) of specialists across the country in modelling infectious diseases to be applied to public needs associated with emerging infectious diseases and pandemics such as COVID-19. [1]☜F1CEB7
⌃
Research interests
Research interests☜☜9FDEF6
■
Nonpharmaceutical Interventions (NPIs)
Nonpharmaceutical Interventions (NPIs)☜☜9FDEF6
⇤
Lisa Kanary
Lisa Kanary☜Instructor, Business Administration in the School of Business and Leadership at Yukon University.☜FFFACD
⇤
04 Intervention and Control
04 Intervention and Control☜As evident in the COVID-19 pandemic, a substantial challenge in managing epidemics is the duration of the application of non-pharmaceutical interventions (NPIs), especially those that disrupt “normal” societal organization and function such as social distancing. These measures quickly become infeasible as pandemic fatigue builds.☜FFFACD
⇤
Ashleigh Tuite
Ashleigh Tuite☜Ashleigh Tuite is an Assistant Professor in the Epidemiology Division at the Dalla Lana School of Public Health at the University of Toronto.☜FFFACD
⇤
David Fisman
David Fisman☜I am a Professor in the Division of Epidemiology at Division of Epidemiology, Dalla Lana School of Public Health at the University of Toronto. I am a Full Member of the School of Graduate Studies. I also have cross-appointments at the Institute of Health Policy, Management and Evaluation and the Department of Medicine, Faculty of Medicine. I serve as a Consultant in Infectious Diseases at the University Health Network.☜FFFACD
⇤
Iain Moyles
Iain Moyles☜Assistant Professor in the Department of Mathematics and Statistics at York University. ☜FFFACD
⇤
James Watmough
James Watmough☜Professor in the Department of Mathematics and Statistics at the University of New Brunswick.☜FFFACD
⇤
Jude Kong
Jude Kong☜Dr. Jude Dzevela Kong is an Assistant Professor in the Department of Mathematics and Statistics at York University and the founding Director of the Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC). ☜FFFACD
⇤
Huaiping Zhu
Huaiping Zhu☜Professor of mathematics at the Department of Mathematics and Statistics at York University, a York Research Chair (YRC Tier I) in Applied Mathematics, the Director of the Laboratory of Mathematical Parallel Systems at the York University (LAMPS), the Director of the Canadian Centre for Diseases Modelling (CCDM) and the Director of the One Health Modelling Network for Emerging Infections (OMNI-RÉUNIS). ☜FFFACD
⇤
Julien Arino
Julien Arino☜Professor and Faculty of Science Research Chair in Fundamental Science with the Department of Mathematics at the University of Manitoba.☜FFFACD
⇤
Beate Sander
Beate Sander☜Canada Research Chair in Economics of Infectious Diseases and Director, Health Modeling & Health Economics and Population Health Economics Research at THETA (Toronto Health Economics and Technology Assessment Collaborative).☜FFFACD
⇤
Jane Heffernan
Jane Heffernan☜Jane Heffernan is a professor of infectious disease modelling in the Mathematics & Statistics Department at York University. She is a co-director of the Canadian Centre for Disease Modelling, and she leads national and international networks in mathematical immunology and the modelling of waning and boosting immunity.☜FFFACD
⇤
Nick Ogden
Nick Ogden☜Nicholas Ogden is a senior research scientist and Director of the Public Health Risk Sciences Division within the National Microbiology Laboratory at the Public Health Agency of Canada.☜FFFACD
⇤
Jacques Bélair
Jacques Bélair☜Professor, Department of Mathematics and Statistics, Université de Montréal☜FFFACD
⇤
Natalie Anne Prystajecky
Natalie Anne Prystajecky☜Natalie Prystajecky is the program head for the Environmental Microbiology program at the BCCDC Public Health Laboratory. She is also a clinical associate professor in the Department of Pathology & Laboratory Medicine at UBC.☜FFFACD
⇤
Amy Greer
Amy Greer☜Canada Research Chair in Population Disease Modelling and an associate professor in the Department of Population Medicine, Ontario Veterinary College at the University of Guelph.☜FFFACD
⇤
Lloyd T. Elliott
Lloyd T. Elliott☜Assistant Professor, Statistics and Actuarial Science at Simon Fraser University.☜FFFACD
⇤
Lindsay Crowshoe
Lindsay Crowshoe☜Assistant Professor & Assistant Dean in the Department of Family Medicine & Indigenous, Local and Global Health Office, University of Calgary.☜FFFACD
⇤
Rita Isabel Henderson
Rita Isabel Henderson☜Assistant Professor in the Cumming School of Medicine, and Full Member at the Hotchkiss Brain Institute at the University of Calgary.☜FFFACD
⇤
Jianhong Wu
Jianhong Wu☜Professor Jianhong Wu is a University Distinguished Research Professor and Senior Canada Research Chair in industrial and applied mathematics at York University. He is also the NSERC Industrial Research Chair in vaccine mathematics, modelling, and manufacturing. ☜FFFACD
⇤
Edward Thommes
Edward Thommes ☜Edward W. Thommes is an Adjunct Professor of Mathematics at the University of Guelph and at York University. He is a Global Modeling Lead in the Modeling, Epidemiology and Data Science (MEDS) team of Sanofi Vaccines, an Affiliate Researcher in the Waterloo Institute for Complexity and Innovation (WICI), and a member of the Strategic Advisory Committee for the Mathematics for Public Health program at the Fields Institute.☜FFFACD
⇤
Monica Cojocaru
Monica Cojocaru☜Professor in the Mathematics & Statistics Department at the University of Guelph. ☜FFFACD
⇤
Seyed Moghadas
Seyed Moghadas☜Seyed Moghadas is an infectious disease modeller whose research includes mathematical and computational modelling in epidemiology and immunology. In particular, he is interested in the theoretical and computational aspects of mathematical models describing the underlying dynamics of infectious diseases, with a particular emphasis on establishing strong links between micro (individual) and macro (population) levels.☜FFFACD
⇤
Mark Loeb
Mark Loeb☜Professor at Pathology and Molecular Medicine (primary), Clinical Epidemiology and Biostatistics in the Department of Pathology and Molecular Medicine at McMaster University. Associate Member, Medicine and Michael G. DeGroote Chair in Infectious Diseases.☜FFFACD
⇤
Swetaprovo Chaudhuri
Swetaprovo Chaudhuri☜Swetaprovo is an Associate Professor in the Institute for Aerospace Studies in the Faculty of Applied Science and Engineering at the University of Toronto.☜FFFACD
⇤
Kumar Murty
Kumar Murty☜Professor Kumar Murty is in the Department of Mathematics at the University of Toronto. His research fields are Analytic Number Theory, Algebraic Number Theory, Arithmetic Algebraic Geometry and Information Security. He is the founder of the GANITA lab, co-founder of Prata Technologies and PerfectCloud. His interest in mathematics ranges from the pure study of the subject to its applications in data and information security.☜FFFACD
⇤
Sharmistha Mishra
Sharmistha Mishra☜Sharmistha Mishra is an infectious disease physician and mathematical modeler and holds a Tier 2 Canadian Research Chair in Mathematical Modeling and Program Science.☜FFFACD
⇥
23/11/16 Julien Arino
23/11/16 Julien Arino☜Introductions and the stochastic phase of an epidemic.☜FFFACD
⇥
Mathematical modelling of human response behaviour during pandemics
Mathematical modelling of human response behaviour during pandemics☜Mathematical modelling of human response behaviour, opinion dynamics, and social influence during pandemics. COVID-19 showed that understanding human response to intervention is essential in mitigating disease spread and forming policy. We are particularly interested in understanding how opinion influence affects vaccine and NPI hesitancy. This project aims to incorporate a broader understanding of intervention and control, which embodies the entire theme.☜FFFACD
⇥
4b Evaluate impact of NPI policy on future disease outcomes
4b Evaluate impact of NPI policy on future disease outcomes☜☜FFFACD
⇥
2022/04/05 Jorge Velasco-Hernandez
2022/04/05 Jorge Velasco-Hernandez☜Modeling behavioral change and COVID-19 containment in Mexico☜FFFACD
⇥
221026 Success or Failure of Nonpharmaceutical Interventions
221026 Success or Failure of Nonpharmaceutical Interventions☜Seminar 3: Success or Failure of Nonpharmaceutical Interventions on Infections Disease Mitigation: Modeling the Impact of Atmospheric Conditions. Speaker: Dr. Juping Ji, October 26, 2022☜FFFACD
⇥
221117 Stochasticity in adherence to nonpharmaceutical interventions
221117 Stochasticity in adherence to nonpharmaceutical interventions☜Seminar 4: The stochasticity in adherence to nonpharmaceutical interventions and booster doses and the mitigation of COVID-19. Speaker: Yi Tan, November 17, 2022.☜FFFACD
⇥
221215 Compliance with social distancing and vaccination for COVID-19
221215 Compliance with social distancing and vaccination for COVID-19☜Seminar 5: An investigation into compliance with social distancing and vaccination for COVID-19. Speaker: Jeta Molla, December 15, 2022☜FFFACD
⇥
One Health Modelling for Emerging Infectious Diseases – Fall 2022
One Health Modelling for Emerging Infectious Diseases – Fall 2022☜OMNI-RÉUNIS and Fields Institute partnered to launch a two-part graduate course on One Health Modelling for Emerging Infectious Diseases in Fall 2022 and Winter 2023. The courses were open to all students, researchers, and professionals interested in learning more about One Health Modelling for Emerging Infectious Diseases.☜FFFACD
⇥
Lecture 15: Controlling infectious disease
Lecture 15: Controlling infectious disease☜2023 AARMS-EIDM Summer School, Lecture 15 Controlling infectious disease by Amy Greer as part of Course 1: Mathematical Epidemiology.☜FFFACD
⇥
230208 Martin Grunnill
230208 Martin Grunnill☜Modelling Disease Mitigation at Mass Gatherings: A Case Study of COVID-19 at the 2022 FIFA World Cup.☜FFFACD
⇥
230412 Jingjing Xu
230412 Jingjing Xu☜Modelling the effect of travel-related policies on disease control in a meta-population structure.☜FFFACD
⇥
231011 Rado Ramasy
231011 Rado Ramasy☜Multilevel mediation analysis: Deciphering the impact of information sources on adherence to restrictive measures during the COVID-19 pandemic.☜FFFACD
⇥
231206 Mortaza Baky Haskuee
231206 Mortaza Baky Haskuee☜Cost-Benefit Analysis of Containment Policies to Control Covid-19.☜FFFACD
⇥
240214 William Ruth
240214 William Ruth☜Statistical Considerations in Multilevel Mediation Analysis.☜FFFACD
⇥
240228 Tanya Philippsen
240228 Tanya Philippsen☜A retrospective modelling analysis on the effects of control measures on SARS-CoV-2 transmission in Canada.☜FFFACD
□
Actuarial science
Actuarial science☜☜9FDEF6
□
Agent-based models
Agent-based models☜☜9FDEF6
□
Agriculture
Agriculture☜☜9FDEF6
□
Animal health
Animal health☜☜9FDEF6
□
Antimicrobial resistance
Antimicrobial resistance☜☜9FDEF6
□
Arthropods
Arthropods☜☜9FDEF6
□
Artificial intelligence
Artificial intelligence☜☜9FDEF6
□
Bayesian analysis
Bayesian analysis☜☜9FDEF6
□
Bioinformatics
Bioinformatics☜☜9FDEF6
□
Biometrics
Biometrics☜☜9FDEF6
□
Biostatistics
Biostatistics☜☜9FDEF6
□
Cancer
Cancer☜☜9FDEF6
□
Category Theory
Category Theory☜☜9FDEF6
□
Causal inference
Causal inference☜☜9FDEF6
□
Cellular biology
Cellular biology☜☜9FDEF6
□
Chikungunya
Chikungunya☜☜9FDEF6
□
Child health
Child health☜☜9FDEF6
□
Cholera
Cholera☜☜9FDEF6
□
Climate change
Climate change☜☜9FDEF6
□
Clinical trials
Clinical trials☜☜9FDEF6
□
Clostridium difficile
Clostridium difficile☜☜9FDEF6
□
Community health
Community health☜☜9FDEF6
□
Conservation
Conservation☜☜9FDEF6
□
Contact tracing
Contact tracing☜☜9FDEF6
□
COPD
COPD☜☜9FDEF6
□
Covid-19
Covid-19☜☜9FDEF6
□
Data mining
Data mining☜☜9FDEF6
□
Decision making
Decision making☜☜9FDEF6
□
Defence
Defence☜☜9FDEF6
□
Dengue
Dengue☜☜9FDEF6
□
Diabetes
Diabetes☜☜9FDEF6
□
Diagnostic testing
Diagnostic testing☜☜9FDEF6
□
Digital Twins
Digital Twins☜“A digital twin is a digital model of an intended or actual real-world physical product, system, or process (a physical twin) that serves as the effectively indistinguishable digital counterpart of it for practical purposes, such as simulation, integration, testing, monitoring, and maintenance.” [1]☜9FDEF6
□
Dynamical systems
Dynamical systems☜☜9FDEF6
□
Ebola
Ebola☜☜9FDEF6
□
Ecology
Ecology☜☜9FDEF6
□
Economics
Economics☜☜9FDEF6
□
Energy
Energy☜☜9FDEF6
□
Enteric infections
Enteric infections☜☜9FDEF6
□
Environment
Environment☜☜9FDEF6
□
Equity
Equity☜☜9FDEF6
□
Ethics
Ethics☜☜9FDEF6
□
Finance
Finance☜☜9FDEF6
□
Food safety
Food safety☜☜9FDEF6
□
Food security
Food security☜☜9FDEF6
□
Foot and Mouth Disease
Foot and Mouth Disease☜☜9FDEF6
□
Forest fires
Forest fires☜☜9FDEF6
□
Games
Games☜☜9FDEF6
□
Gender
Gender☜☜9FDEF6
□
Genomics
Genomics☜☜9FDEF6
□
Global health
Global health☜☜9FDEF6
□
Graphs
Graphs☜☜9FDEF6
□
Health economics
Health economics☜☜9FDEF6
□
Hepatitis
Hepatitis☜☜9FDEF6
□
HIV
HIV☜☜9FDEF6
□
Homelessness
Homelessness☜☜9FDEF6
□
Human papillomavirus (HPV)
Human papillomavirus (HPV)☜☜9FDEF6
□
Immunology
Immunology☜☜9FDEF6
□
Indigenous health
Indigenous health☜☜9FDEF6
□
Influenza
Influenza☜☜9FDEF6
□
Informatics
Informatics☜☜9FDEF6
□
Insurance
Insurance☜☜9FDEF6
□
Livestock
Livestock☜☜9FDEF6
□
Lyapunov functions
Lyapunov functions☜☜9FDEF6
□
Lyme disease
Lyme disease☜☜9FDEF6
□
Machine learning
Machine learning☜☜9FDEF6
□
Malaria
Malaria☜☜9FDEF6
□
Manufacturing
Manufacturing☜☜9FDEF6
□
Markov chain
Markov chain☜Markov chain Monte Carlo methods (McMC)☜9FDEF6
□
Mental health
Mental health☜☜9FDEF6
□
Microbiology
Microbiology☜☜9FDEF6
□
Mobility
Mobility☜☜9FDEF6
□
Model‐informed drug development
Model‐informed drug development☜☜9FDEF6
□
Mortality
Mortality☜☜9FDEF6
□
Mosquitoes
Mosquitoes☜☜9FDEF6
□
mpox
mpox☜☜9FDEF6
□
Natural resource management
Natural resource management☜☜9FDEF6
□
Neisseria meningitidis
Neisseria meningitidis☜☜9FDEF6
□
Neural networks
Neural networks☜☜9FDEF6
□
Nutrition
Nutrition☜☜9FDEF6
□
Pathogens
Pathogens☜☜9FDEF6
□
Pertussis
Pertussis☜☜9FDEF6
□
Physics
Physics☜☜9FDEF6
□
Pneumonia
Pneumonia☜☜9FDEF6
□
Primary care
Primary care☜☜9FDEF6
□
Probiotics
Probiotics☜☜9FDEF6
□
Psychology
Psychology☜☜9FDEF6
□
Rabies
Rabies☜☜9FDEF6
□
Race
Race☜☜9FDEF6
□
Respiratory infections
Respiratory infections☜☜9FDEF6
□
Respiratory syncytial virus (RSV)
Respiratory syncytial virus (RSV)☜☜9FDEF6
□
SARS
SARS☜☜9FDEF6
□
Schools
Schools☜☜9FDEF6
□
Sentiment analysis
Sentiment analysis☜☜9FDEF6
□
Serosurveillance
Serosurveillance☜☜9FDEF6
□
Sexually transmitted infections
Sexually transmitted infections☜☜9FDEF6
□
Simulation
Simulation☜☜9FDEF6
□
Social determinants
Social determinants☜☜9FDEF6
□
Social networks
Social networks☜☜9FDEF6
□
Sociology
Sociology☜☜9FDEF6
□
Spatio-temporal analysis
Spatio-temporal analysis☜☜9FDEF6
□
Stem cells
Stem cells☜☜9FDEF6
□
Streptococcus pneumoniae
Streptococcus pneumoniae☜☜9FDEF6
□
Substance use
Substance use☜☜9FDEF6
□
Surveillance
Surveillance☜☜9FDEF6
□
Sustainability
Sustainability☜☜9FDEF6
□
Syndemics
Syndemics☜☜9FDEF6
□
Synthesis
Synthesis☜☜9FDEF6
□
Text mining
Text mining☜☜9FDEF6
□
Tuberculosis
Tuberculosis☜☜9FDEF6
□
Vaccination
Vaccination☜☜9FDEF6
□
Wastewater-based surveillance (WBS)
Wastewater-based surveillance (WBS) ☜☜9FDEF6
□
West Nile virus
West Nile virus☜☜9FDEF6
□
Workforce impact
Workforce impact☜☜9FDEF6
□
Zika
Zika☜☜9FDEF6
□
Zoonosis
Zoonosis☜☜9FDEF6
□
Graph of this discussion
Graph of this discussion☜Click this to see the whole debate, excluding comments, in graphical form☜dcdcdc
Enter the title of your article
Enter a short (max 500 characters) summation of your article
Click the button to enter task scheduling information
Open
Enter the main body of your article
Prefer more work space? Try the
big editor
Enter task details
Message text
Select assignee(s)
Due date (click calendar)
RadDatePicker
RadDatePicker
Open the calendar popup.
Calendar
Title and navigation
Title and navigation
<<
<
November 2024
>
<<
November 2024
S
M
T
W
T
F
S
44
27
28
29
30
31
1
2
45
3
4
5
6
7
8
9
46
10
11
12
13
14
15
16
47
17
18
19
20
21
22
23
48
24
25
26
27
28
29
30
49
1
2
3
4
5
6
7
Reminder
No reminder
1 day before due
2 days before due
3 days before due
1 week before due
Ready to post
Copy to text
Enter
Cancel
Task assignment(s) have been emailed and cannot now be altered
Lock
Cancel
Save
Comment graphing options
Choose comments:
Comment only
Whole thread
All comments
Choose location:
To a new map
To this map
New map options
Select map ontology
Options
Standard (default) ontology
College debate ontology
Hypothesis ontology
Influence diagram ontology
Story ontology
Graph to private map
Cancel
Proceed
+Comments (
0
)
- Comments
Add a comment
Newest first
Oldest first
Show threads
+Citations (
39
)
- Citations
Add new citation
List by:
Citerank
Map
+About
- About
Entered by:-
David Price
NodeID:
#715328
Node type:
Interest
Entry date (GMT):
11/15/2023 6:54:00 PM
Last edit date (GMT):
12/9/2023 2:26:00 AM
Show other editors
Incoming cross-relations:
15
Outgoing cross-relations:
26
Average rating:
0
by
0
users
Enter comment
Select article text to quote
Cancel
Enter
welcome text
First name
Last name
Email
Skip
Join
x
Select file to upload